The FDA has granted full approval for the use of brexucabtagene autoleucel in adults with relapsed or refractory mantle cell lymphoma, based on confirmatory ZUMA-2 data.
A double-blind, placebo-controlled cross-over trial published in BMC Gastroenterology evaluated whether 12 g/day of chicory inulin improves bowel habits, patient-reported outcomes, and gut microbiota...
The FDA has approved icotrokinra, an oral interleukin-23 receptor antagonist, for patients aged 12 years and older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or...
New guideline recommendations from the ACC/AHA and 9 partner organizations prioritize earlier treatment, refined atherosclerotic cardiovascular disease risk prediction, and broader use of lipid biomarkers...
In a randomized controlled trial of adults with Rome IV irritable bowel syndrome without constipation, investigators found that a Mediterranean-style low-FODMAP diet produced greater symptom improvement,...
Primary care clinicians routinely counsel patients whose eating patterns reflect diverse cultural traditions. This resource offers practical, evidence-based strategies for supporting balanced nutrition...
A multinational cross-sectional survey of children and adolescents with moderate-to-severe atopic dermatitis found substantial disease burden, with distinct physical and psychosocial impacts by age group.
...
HHS and the Department of Agriculture unveiled new dietary guidelines and an updated food pyramid for Americans. According to HHS, these changes mark a shift toward prioritizing health outcomes rather than...
